Review of medications used in juvenile rheumatoid arthritis

Bridgette Guthrie; Kelly A. Rouster-Stevens; Sally L. Reynolds

doi:10.1097/PEC.0b013e31802c61ae

Review of medications used in juvenile rheumatoid arthritis

Bridgette Guthrie^*, Kelly A. Rouster-Stevens, Sally L. Reynolds

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

Juvenile rheumatoid arthritis is a chronic condition. The goal of therapy is to control pain, preserve joint range of motion and function, minimize systemic complications, and assist in normal growth and development. Recent advances in understanding the pathophysiology of arthritis have expanded the treatment of this chronic condition. Many medications including nonsteroidal anti-inflammatory agents, disease-modifying antirheumatic drugs, biologic agents, and cytotoxic agents are available for treating juvenile rheumatoid arthritis. Emergency medicine physicians should be familiar with the different classes and adverse effects of these drugs.

Original language	English (US)
Pages (from-to)	38-46
Number of pages	9
Journal	Pediatric emergency care
Volume	23
Issue number	1
DOIs	https://doi.org/10.1097/PEC.0b013e31802c61ae
State	Published - Jan 2007

Keywords

Juvenile rheumatoid arthritis
Medication
Therapy

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Emergency Medicine

Access to Document

10.1097/PEC.0b013e31802c61ae

Cite this

@article{3093fc13477642dba77a930ac5e847a7,

title = "Review of medications used in juvenile rheumatoid arthritis",

abstract = "Juvenile rheumatoid arthritis is a chronic condition. The goal of therapy is to control pain, preserve joint range of motion and function, minimize systemic complications, and assist in normal growth and development. Recent advances in understanding the pathophysiology of arthritis have expanded the treatment of this chronic condition. Many medications including nonsteroidal anti-inflammatory agents, disease-modifying antirheumatic drugs, biologic agents, and cytotoxic agents are available for treating juvenile rheumatoid arthritis. Emergency medicine physicians should be familiar with the different classes and adverse effects of these drugs.",

keywords = "Juvenile rheumatoid arthritis, Medication, Therapy",

author = "Bridgette Guthrie and Rouster-Stevens, {Kelly A.} and Reynolds, {Sally L.}",

year = "2007",

month = jan,

doi = "10.1097/PEC.0b013e31802c61ae",

language = "English (US)",

volume = "23",

pages = "38--46",

journal = "Pediatric emergency care",

issn = "0749-5161",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Review of medications used in juvenile rheumatoid arthritis

AU - Guthrie, Bridgette

AU - Rouster-Stevens, Kelly A.

AU - Reynolds, Sally L.

PY - 2007/1

Y1 - 2007/1

N2 - Juvenile rheumatoid arthritis is a chronic condition. The goal of therapy is to control pain, preserve joint range of motion and function, minimize systemic complications, and assist in normal growth and development. Recent advances in understanding the pathophysiology of arthritis have expanded the treatment of this chronic condition. Many medications including nonsteroidal anti-inflammatory agents, disease-modifying antirheumatic drugs, biologic agents, and cytotoxic agents are available for treating juvenile rheumatoid arthritis. Emergency medicine physicians should be familiar with the different classes and adverse effects of these drugs.

AB - Juvenile rheumatoid arthritis is a chronic condition. The goal of therapy is to control pain, preserve joint range of motion and function, minimize systemic complications, and assist in normal growth and development. Recent advances in understanding the pathophysiology of arthritis have expanded the treatment of this chronic condition. Many medications including nonsteroidal anti-inflammatory agents, disease-modifying antirheumatic drugs, biologic agents, and cytotoxic agents are available for treating juvenile rheumatoid arthritis. Emergency medicine physicians should be familiar with the different classes and adverse effects of these drugs.

KW - Juvenile rheumatoid arthritis

KW - Medication

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33846274915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846274915&partnerID=8YFLogxK

U2 - 10.1097/PEC.0b013e31802c61ae

DO - 10.1097/PEC.0b013e31802c61ae

M3 - Review article

C2 - 17228221

AN - SCOPUS:33846274915

SN - 0749-5161

VL - 23

SP - 38

EP - 46

JO - Pediatric emergency care

JF - Pediatric emergency care

IS - 1

ER -

Review of medications used in juvenile rheumatoid arthritis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this